🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very happy to get this contract and keep doing science! 🙂🔬🧫🧬

👏👏👏

💪

Is it novel or not

I am glad to present our last results at #KindPhillipp2023

Máxima asistencia a nuestra Reunion Anual 2023. Cada año nos superamos #Ricors/Terav Instituto de Salud Carlos III (ISCIII) TERAV

Reunión anual #TERAV2023 en Alicante. Gracias a TERAV @saludISCIII por esta iniciativa y por darnos la oportunidad de poder aportar nuestro granito de arena en la investigación nacional de terapias avanzadas. Es un placer seguir aprendiendo todos juntos! Seguimos trabajando!

First day of #VHIOBBVASymposium cell-based therapies in oncology. Proud of Aïda Falgàs for her hard work and presentation today! 🚀

🎙 Exciting research by Aïda Falgàs, Josep Carreras Leukaemia Research Institute (IJC), on improving CD19 targeted CAR-T - cell therapy for B-acute lymphoblastic leukemia patients. Blocking the Galectin9-Tim3 pathway shows promising results for increased CAR T-cell persistence and cytotoxicity. #VHIOBBVASymposium

Proud to share our latest work in STM. The best anti-BCMA killers for Multiple Myeloma. Local leadership in Menendez Lab - Clara Bueno & Aïda Falgàs. The guiding force & "the boss": Luis Álvarez-Vallina and team Hospital 12 Octubre.Thanks 4 the opportunity Luis! science.org/doi/10.1126/sc…

🚨STAb-T cells perform better than CAR-T cells against Multiple Myeloma in preclinical models, a recent study at Science Translational Medicine found. Great joint effort by Luis Álvarez-Vallina Menendez Lab CNIO Stop Cancer Clara Bueno Aïda Falgàs Read the full story 👇 carrerasresearch.org/en/news/a-new-…

The pleasure has been mine for having had the opportunity to learn from all of you! 🔬🧬

🏃🏻‍♀️ Aún estáis a tiempo de apuntaros a la carrera solidaria 𝗢𝗿𝗶𝗲𝗻𝘁𝗮𝗱𝗼𝘀 𝗵𝗮𝘀𝘁𝗮 𝗹𝗮 𝗺𝗲́𝗱𝘂𝗹𝗮 de Héroes hasta la Médula que se celebra el próximo 12 de mayo. Inscripciones y toda la info aquí 👇🏼oveleta.com/omedula/omedul… Juntos somos imparables 💪🏼 🧡

Funny days at the #TERAV 2024 annual meeting. Lots of interesting science & a great opportunity for networking TERAV

🎄🎅🏼 HOHOHO 🎅🏼🎄 Today the Menendez lab celebrating Christmas lunch 🎉 Do you already know who your Secret Santa is? 🤭 🎄🎅🏼HOHOHO 🎅🏼🎄 Merry Christmas to all!

Great collaboration with the Cancer Immunotherapy group lead by Dr Alvarez Vallina CNIO Stop Cancer Hospital Universitario 12 de Octubre as well as Orfao Lab Hospital Clínic and many others. Great leadership by Aïda Falgàs Clara Bueno!!! Thanks all for making it possible

A privilege to be part of this study published in @BloodJournal and led by Aïda Falgàs Clara Bueno Menendez Lab Josep Carreras Leukaemia Research Institute (IJC) to develop a CAR-T strategy that tricks B-ALL with molecular decoys. Thanks to RLázaro-Gorines and cancer immunotherapy team CNIO Stop Cancer Hospital Universitario 12 de Octubre

Thrilled to share our paper published in Blood Journal! Josep Carreras Leukaemia Research Institute (IJC) CNIO Stop Cancer Hospital Clínic Hospital Universitario 12 de Octubre Huge thanks to everyone involved in this work! Check out the full paper! lnkd.in/dE_82UpY #Immunotherapy #CAR19 #BALL

Happy to share our latest work Menendez Lab Clara Bueno Aïda Falgàs Josep Carreras Leukaemia Research Institute (IJC) in collaboration with the Luis Álvarez-Vallina Lab at CNIO Stop Cancer and Hospital Universitario 12 de Octubre on new CD22 and CD19 T cell redirecting strategies spanning CAR &T-cell engagers (STabs). pubmed.ncbi.nlm.nih.gov/40306957/

We thank ACIR for highlighting our paper, 'CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukaemia progression' published in Journal for ImmunoTherapy of Cancer, co-authored by Javier Arroyo Hospital Universitario 12 de Octubre CNIO Stop Cancer & Aïda Falgàs Josep Carreras Leukaemia Research Institute (IJC)